Literature DB >> 8894362

Trends in the clinical presentation of temporal arteritis in Israel: reflection of increased physician awareness.

G Nesher1, A Rubinow, M Sonnenblick.   

Abstract

We have noticed significant changes in the clinical presentation in patients diagnosed with temporal arteritis in Israel between 1980-1992 compared to patients diagnosed prior to 1977. At the time of diagnosis 57% of the patients were older than 75 years, compared to only 23% within this age group in the previous period. There was an increase in the number of nonspecific and unusual presenting symptoms such as weakness, respiratory and neurological symptomatology, and a decreased proportion of patients presenting with the "classical" manifestation such as headaches, temporal tenderness and visual symptoms. The time from presentation to diagnosis was shortened significantly. It is suggested that these changes are largely due to the increasing awareness among physicians to the various manifestations of this conditions.

Entities:  

Mesh:

Year:  1996        PMID: 8894362     DOI: 10.1007/bf02229646

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

Review 2.  Nonclassical organ involvement in temporal arteritis.

Authors:  M Sonnenblick; G Nesher; A Rosin
Journal:  Semin Arthritis Rheum       Date:  1989-12       Impact factor: 5.532

3.  Epidemiology of temporal arteritis in Israel.

Authors:  G Friedman; B Friedman; J Benbassat
Journal:  Isr J Med Sci       Date:  1982-02

4.  An arteritis with special reference to polymyalgia arteritica.

Authors:  G Ostberg
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1973

5.  Temporal arteritis in Israel. A review of 47 patients.

Authors:  M Fainaru; G Friedman; B Friedman
Journal:  J Rheumatol       Date:  1979 May-Jun       Impact factor: 4.666

6.  Giant cell arteritis in Jerusalem: a 12-year epidemiological study.

Authors:  M Sonnenblick; G Nesher; Y Friedlander; A Rubinow
Journal:  Br J Rheumatol       Date:  1994-10

7.  Temporal arteritis: the silent presentation and delay in diagnosis.

Authors:  G D Desmet; D C Knockaert; H J Bobbaers
Journal:  J Intern Med       Date:  1990-04       Impact factor: 8.989

8.  Epidemiology of biopsy-proven giant cell arteritis (GCA).

Authors:  E Nordborg; B A Bengtsson
Journal:  J Intern Med       Date:  1990-04       Impact factor: 8.989

9.  Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985.

Authors:  E B Machado; C J Michet; D J Ballard; G G Hunder; C M Beard; C P Chu; W M O'Fallon
Journal:  Arthritis Rheum       Date:  1988-06
  9 in total
  4 in total

Review 1.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Towards a new clinical spectrum in giant cell arteritis.

Authors:  M A Gonzalez-Gay; R Blanco; M Vazquez-Caruncho
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 3.  Visual loss and other cranial ischaemic complications in giant cell arteritis.

Authors:  Alessandra Soriano; Francesco Muratore; Nicolò Pipitone; Luigi Boiardi; Luca Cimino; Carlo Salvarani
Journal:  Nat Rev Rheumatol       Date:  2017-07-06       Impact factor: 20.543

4.  Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort.

Authors:  Abha G Singh; Tanaz A Kermani; Cynthia S Crowson; Cornelia M Weyand; Eric L Matteson; Kenneth J Warrington
Journal:  J Rheumatol       Date:  2014-12-15       Impact factor: 4.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.